KongstvedtP.PlocherP. (1998) Best Practices in Medical Management, Aspen Publishing, NY.
2.
PilnickA.DingwallR.StarkeyK. (2001) ‘Disease management: Definitions, difficulties and future directions’, Bulletin of the World Health Organization, p. 79 (for review).
3.
RichardsT. (1998) ‘Disease management in Europe’, British Medical Journal317, 426427.
4.
Decision Resources Inc. (2003) Spectrum Pharmacoeconomics. Prospects for Disease Management in Europe, Decision Resources Inc.
5.
Cap Gemini Ernst & Young (2002) Optimized Care — Positionierung der Life Sciences Industrie zwischen Disease Management und Patientenbindung, Cap Gemini Ernst & Young.
6.
CGE&Y/INSEAD (2003) Vision & Reality Survey. Prescriptions for the Smart and Lean Pharmaceutical Company, CGE&Y/INSEAD.
7.
LieblA.NeissA.SpannheimerA. (2001) ‘Kosten des Typ-2-Diabetes in Deutschland’, Deutsche Medizinische Wochenschrift126, 585589.